The U.S. government is set to end enhanced screening of some international passengers for COVID-19 and drop requirements that travelers coming from the targeted countries arrive at 15 designated U.S. airports, according to U.S. and airline officials and a government document seen by Reuters.
FILE PHOTO: People walk around the terminal at the John F. Kennedy International Airport in New York, U.S., March 9, 2020. REUTERS/Eduardo Munoz/File Photo
The administration in February imposed enhanced screening requirements on travelers who had been in China, the United Kingdom, Brazil, Iran and the Schengen region of Europe, and barred most non-U.S. citizens who have been in those locations from coming to the United States. Those travelers, who numbered around 6,750 a day as of late August, undergo visual observations, temperature checks and complete traveler declarations. Anyone showing signs of illness or possible exposure is referred for public health assessments.Last month, Reuters reported that the Trump administration’s efforts to require airlines to collect contact tracing information from U.S.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Greece's Moria refugee camp, holding 12,500, engulfed in flames amid COVID-19 unrest'Not much has been left standing,' MSF Head of Mission in Greece Stephan Oberreit told Newsweek.
Read more »
AstraZeneca puts leading COVID-19 vaccine trial on hold over safety concernAstraZeneca Plc on Tuesday said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine because of an unexplained illness in a study participant.
Read more »
AstraZeneca Pauses COVID-19 Vaccine Trial Due To Volunteer's IllnessNPR's Noel King talks to Paul Offit of the Vaccine Education Center at Children's Hospital of Philadelphia, about the coronavirus vaccine trial developed by AstraZeneca and the University of Oxford.
Read more »
AstraZeneca suspends leading COVID-19 vaccine trials after a participant's illnessAstraZeneca Plc said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.
Read more »
Senate expected to vote on COVID-19 relief bill this weekThe slimmed-down proposal includes $105 billion for schools and a two-year tax credit for school choice, as well as $29 billion for vaccines and $16 billion for testing. It does not include another round of direct payment checks to Americans.
Read more »
How To Clean Your N95 Mask Or Face Covering With Covid-19 CoronavirusFace coverings and masks that can serve as filters should be handled differently.
Read more »